Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  

iTTP

Important Webinar on Care for Patients with iTTP - ISTH
Feb 2, 2026, 17:44 | Voices
Important Webinar on Care for Patients with iTTP - ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn: "New webinar alert!…
Louise St Germain Bannon: ISTH Education is Off to An Exciting Start in 2026
Jan 15, 2026, 15:09 | Insight
Louise St Germain Bannon: ISTH Education is Off to An Exciting Start in 2026
Louise St Germain Bannon, Director of Membership, Marketing and External Relations of ISTH, shared on…
Wolfgang Miesbach: Caplacizumab as Frontline Therapy for iTTP
Dec 20, 2025, 12:07 | Science
Wolfgang Miesbach: Caplacizumab as Frontline Therapy for iTTP
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: “Caplacizumab as Frontline Therapy…
Wolfgang Miesbach on Linus Völker's Presentation of Caplacizumab as Frontline Therapy for iTTP
Dec 17, 2025, 06:28 | Insight
Wolfgang Miesbach on Linus Völker's Presentation of Caplacizumab as Frontline Therapy for iTTP
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: ''Caplacizumab as Frontline…
Kristof Vercruysse on ''First in Human'' Presented at ASH25
Dec 11, 2025, 15:05 | Insight
Kristof Vercruysse on ''First in Human'' Presented at ASH25
Kristof Vercruysse, CEO and Co-Founder at TargED Biopharmaceuticals, reposted from TargED Biopharmaceuticals on LinkedIn: ''Back in…
ASH25 Day 3: Don’t Miss The Highlights
Dec 8, 2025, 22:24 | Insight
ASH25 Day 3: Don’t Miss The Highlights
The American Society of Hematology Congress 2025 (ASH25) is officially underway in Orlando, Florida, from…
ASH25 Day 2: Don't Miss The Highlights
Dec 7, 2025, 18:43 | Insight
ASH25 Day 2: Don't Miss The Highlights
The American Society of Hematology Congress 2025 (ASH25) is officially underway in Orlando, Florida, from…
Nishant Tiwari Reports Zero Relapses with Scheduled Rituximab in TTP
Dec 7, 2025, 06:07 | Blog
Nishant Tiwari Reports Zero Relapses with Scheduled Rituximab in TTP
Nishant Rajendra Tiwari, Hematology-Oncology Fellow at OU Health Stephenson Cancer Center, posted on X: ''Pre-emptive…
Wolfgang Miesbach: iTTP Remission ≠ Cure. The Vascular Injury Persists
Dec 7, 2025, 05:50 | Science
Wolfgang Miesbach: iTTP Remission ≠ Cure. The Vascular Injury Persists
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: "iTTP remission ≠ cure.…
Silvia Escribano Serrat Explores A Potential Role of EASIX as a Predictor of Refractoriness and Mortality in iTTP
Nov 17, 2025, 17:26 | Science
Silvia Escribano Serrat Explores A Potential Role of EASIX as a Predictor of Refractoriness and Mortality in iTTP
Silvia Escribano Serrat, Research Fellow at Memorial Sloan Kettering Cancer Center, shared on LinkedIn: ''I…
Binish Javed and Colleagues on Underestimation of Cardiovascular Risk Prediction Scores in iTTP
Oct 2, 2025, 05:03 | Science
Binish Javed and Colleagues on Underestimation of Cardiovascular Risk Prediction Scores in iTTP
RPTH Journal shared on LinkedIn: ''This new study looks for long-term risk of cardiovascular events…
Flora Peyvandi on Caplacizumab: Which VWF Assays Truly Measure Treatment Effectiveness?
Sep 10, 2025, 08:20 | Science
Flora Peyvandi on Caplacizumab: Which VWF Assays Truly Measure Treatment Effectiveness?
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of…
JAMA Review: Immune Thrombotic Thrombocytopenic Purpura (iTTP)
Aug 14, 2025, 12:52 | Insight
JAMA Review: Immune Thrombotic Thrombocytopenic Purpura (iTTP)
JAMA shared an insightful post on X: “Immune thrombotic thrombocytopenic purpura (iTTP) is a rare…
All: 13 Posts: 1 - 100
NewsFeed